Vitamin D: Who Actually Needs to Supplement

```html

• Deficiency is common but not universal: roughly 24% of U.S. adults have insufficient vitamin D levels, but supplementation benefits those with confirmed deficiency most clearly.
• Blood testing is the only reliable way to know whether you actually need a vitamin D supplement — symptoms alone are not specific enough.
• Certain groups face substantially higher risk of deficiency, including older adults, people with darker skin tones, those with fat-malabsorption conditions, and people with limited sun exposure.
• Supplementation at evidence-based doses (typically 600–2,000 IU/day for most adults) is considered safe, but more is not always better — toxicity is possible at very high doses.
• The evidence on supplementation benefits for people who are not deficient is more limited than headlines often suggest, particularly for cancer prevention and cardiovascular outcomes.

Why Vitamin D Gets So Much Attention

Vitamin D occupies an unusual space in nutrition science: it is technically a hormone precursor, it is made in the skin under UV-B radiation, and it is found in very few foods in meaningful quantities. That combination makes deficiency genuinely plausible for large portions of the population — and it also makes vitamin D supplement marketing easy to amplify beyond what the research actually supports.

Vitamin D receptors appear in nearly every tissue in the body, from bone cells to immune cells to cardiac muscle (Holick, 2007). That biological ubiquity has led researchers to investigate links between vitamin D status and an enormous range of health outcomes, from fractures to depression to infectious disease. Some of those associations are robust; many others have weakened or disappeared in rigorous randomized controlled trials. The goal here is to help you understand where the evidence is solid, where it is suggestive, and where supplementation is likely unnecessary.

How Deficiency Is Defined — and Who Is Actually at Risk

Vitamin D status is measured as serum 25-hydroxyvitamin D [25(OH)D]. Most major clinical organizations, including the Endocrine Society and the Institute of Medicine (now the National Academy of Medicine), define deficiency as a level below 20 ng/mL and insufficiency as 20–29 ng/mL, though some endocrinologists use a higher threshold of 30 ng/mL for optimal status (Holick et al., 2011).

Nationally representative data from NHANES found that approximately 5% of U.S. adults meet the strict definition of deficiency (<12 ng/mL) and about 24% are insufficient (<20 ng/mL), with considerably higher rates in non-Hispanic Black adults (Forrest & Stuhldreher, 2011). These numbers reflect real population-level risk, but they also mean the majority of adults are not deficient and may not benefit meaningfully from supplementation.

Groups at elevated risk include:

• Older adults (65+): Skin efficiency in converting UV-B to vitamin D declines with age, and kidney conversion of the precursor to active vitamin D also diminishes (Holick, 2007).
• People with darker skin tones: Higher melanin content reduces UV-B absorption, requiring longer sun exposure to produce equivalent vitamin D (Forrest & Stuhldreher, 2011).
• People who avoid sun exposure: This includes those who live at high latitudes, work indoors, use significant sun protection, or wear full-coverage clothing for cultural or medical reasons.
• People with fat-malabsorption conditions: Vitamin D is fat-soluble, so conditions like Crohn's disease, celiac disease, cystic fibrosis, and bariatric surgery can impair its absorption (Holick et al., 2011).
• People with obesity: Vitamin D appears to sequester in adipose tissue, reducing bioavailability in the bloodstream (Wortsman et al., 2000).
• Exclusively breastfed infants: Breast milk is a poor source of vitamin D; the American Academy of Pediatrics recommends 400 IU/day supplementation from birth.

What the Evidence Actually Supports

Bone health is the strongest and most established domain. Vitamin D and calcium work in concert to support calcium absorption in the gut and bone mineralization. In people who are deficient, supplementation reduces the risk of rickets in children and osteomalacia in adults. For fracture prevention in older adults, a 2022 meta-analysis found that vitamin D supplementation alone — without adequate calcium — did not significantly reduce fracture risk, but combined vitamin D and calcium supplementation modestly lowered hip fracture incidence in institutionalized older adults (Yao et al., 2022).

Immune function is a second area with meaningful evidence. Vitamin D modulates both innate and adaptive immune responses, and observational studies have long linked low levels to higher respiratory infection rates. A large individual participant data meta-analysis found that daily or weekly vitamin D supplementation reduced the risk of acute respiratory tract infection overall, with the most pronounced effect in participants who were severely deficient at baseline (Martineau et al., 2017). This does not mean supplementation prevents specific infections in people with normal levels.

Falls in older adults represent a third area. The U.S. Preventive Services Task Force (USPSTF) has previously cited evidence that vitamin D supplementation may reduce fall risk in community-dwelling older adults, though more recent analyses have been less consistent, and the USPSTF updated its guidance in 2021 to conclude that evidence for fall prevention is insufficient to make a broad recommendation for asymptomatic adults.

Cancer, cardiovascular disease, cognitive decline, and mood disorders are areas where observational data generated significant excitement but randomized trials have been sobering. The VITAL trial — a large, well-designed RCT of 2,000 IU vitamin D3 daily in nearly 26,000 U.S. adults — found no significant reduction in incident cancer or major cardiovascular events in the overall population, though it did observe a potential reduction in cancer mortality after several years of follow-up that warrants further study (Manson et al., 2019). These findings illustrate a recurring pattern in nutrition research: associations seen in observational studies do not always survive the test of randomization.

How Much Vitamin D Do You Need?

The National Academy of Medicine's Dietary Reference Intakes set the Recommended Dietary Allowance (RDA) at 600 IU/day for adults up to age 70 and 800 IU/day for adults over 70, with a tolerable upper intake level of 4,000 IU/day (Institute of Medicine, 2011). The Endocrine Society's clinical practice guideline for people at risk of deficiency suggests that 1,500–2,000 IU/day may be required to consistently achieve serum levels above 30 ng/mL (Holick et al., 2011).

For people with confirmed severe deficiency, clinicians often prescribe higher short-term loading doses — sometimes 50,000 IU weekly for 8–12 weeks — before transitioning to maintenance dosing. These high doses are prescription-level interventions based on measured blood levels and should not be self-initiated.

Vitamin D3 (cholecalciferol) — the form produced in skin and found in animal-based foods — raises serum 25(OH)D more effectively than vitamin D2 (ergocalciferol), which is plant-derived, making D3 the generally preferred form in supplements (Tripkovic et al., 2012).

It is worth emphasizing that taking more than you need carries real risk. Vitamin D toxicity — hypercalcemia — is rare at doses under 4,000 IU/day but has been documented at sustained high doses, causing nausea, weakness, kidney stones, and in extreme cases, organ damage. Toxicity almost never results from sun exposure; it is a hazard of excessive supplementation.

Getting Tested: What a Blood Test Tells You

A serum 25(OH)D test — sometimes ordered as "vitamin D, 25-hydroxy" — is the standard measure of vitamin D status. It is widely available and typically covered by insurance when ordered for at-risk individuals or those with symptoms consistent with deficiency (bone pain, proximal muscle weakness, fatigue).

One important caveat: population-level testing has become extremely common in recent years, and some clinical organizations, including the U.S. Preventive Services Task Force, have concluded that routine screening of asymptomatic adults without known risk factors is not currently supported by sufficient evidence of benefit. This does not mean testing is useless — it means that blanket population screening may catch many mildly low values whose treatment benefit is unclear.

If you fall into one of the higher-risk categories described above, or have symptoms that could plausibly relate to deficiency, testing is a reasonable conversation to have with your clinician before starting a supplement.

What to Do With This Information

Here is a practical framework for thinking through your own situation:

• If you have a confirmed deficiency (below 20 ng/mL): Supplementation is clinically appropriate, and your clinician can advise on dose based on how low your level is and your individual health context. Vitamin D3 is the preferred form.
• If you are in a high-risk group (older adult, limited sun exposure, darker skin tone, fat-malabsorption condition, obesity) but have not been tested: ask your clinician about getting a 25(OH)D level checked. A moderate supplementation dose of 1,000–2,000 IU/day is generally considered safe in the interim, but testing lets you avoid both under- and over-treatment.
• If you are a generally healthy adult with no known risk factors and no symptoms: The evidence does not robustly support broad supplementation. Your diet (fatty fish, egg yolks, fortified dairy and plant milks) and reasonable sun exposure may be sufficient. Routine testing in this group is not universally recommended.
• If you are considering very high doses (above 4,000 IU/day): Do not do this without a measured blood level and clinical oversight. Toxicity is real.
• For infants who are breastfed: Discuss 400 IU/day supplementation with your pediatrician — this is a well-supported recommendation regardless of the mother's vitamin D status.

Food sources worth including in your diet: salmon (about 570 IU per 3-oz serving of sockeye), canned tuna, egg yolks, and vitamin D-fortified foods such as milk, orange juice, and many cereals and plant-based milk alternatives. These rarely get people to sufficiency alone if they are severely deficient, but they meaningfully contribute to overall intake.

Sun exposure is complicated: UV-B intensity sufficient for skin synthesis only exists at most U.S. latitudes from roughly late spring through early fall, and dermatological guidance to limit unprotected sun exposure for skin cancer risk reduction creates a genuine tension that vitamin D supplementation can help resolve — particularly for higher-risk individuals.

This article is for informational purposes only and does not constitute medical advice. Talk to your clinician before starting, stopping, or changing any supplement regimen, particularly if you have an underlying health condition or take prescription medications.

References

• Forrest, K. Y. Z., & Stuhldreher, W. L. (2011). Prevalence and correlates of vitamin D deficiency in US adults. Nutrition Research, 31(1), 48–54. https://doi.org/10.1016/j.nutres.2010.12.001
• Holick, M. F. (2007). Vitamin D deficiency. New England Journal of Medicine, 357(3), 266–281. https://doi.org/10.1056/NEJMra070553
• Holick, M. F., Binkley, N. C., Bischoff-Ferrari, H. A., Gordon, C. M., Hanley, D. A., Heaney, R. P., Murad, M. H., & Weaver, C. M. (2011). Evaluation, treatment, and prevention of vitamin D deficiency: An Endocrine Society clinical practice guideline. Journal of Clinical Endocrinology & Metabolism, 96(7), 1911–1930. https://doi.org/10.1210/jc.2011-0385
• Institute of Medicine. (2011). Dietary Reference Intakes for Calcium and Vitamin D. National Academies Press. https://doi.org/10.17226/13050
• Manson, J. E., Cook, N. R., Lee, I. M., Christen, W., Bassuk, S. S., Mora, S., Gibson, H., Gordon, D., Copeland, T., D'Agostino, D., Friedenberg, G., Ridge, C., Bubes, V., Giovannucci, E. L., Willett, W. C., & Buring, J. E. (2019). Vitamin D supplements and prevention of cancer and cardiovascular disease. New England Journal of Medicine, 380(1), 33–44. https://doi.org/10.1056/NEJMoa1809944
• Martineau, A. R., Jolliffe, D. A., Hooper, R. L., Greenberg, L., Aloia, J. F., Bergman, P., Dubnov-Raz, G., Esposito, S., Ganmaa, D., Ginde, A. A., Goodall, E. C., Grant, C. C., Griffiths, C. J., Janssens, W., Laaksi, I., Manaseki-Holland, S., Mauger, D., Murdoch, D. R., Neale, R., … Camargo, C. A. (2017). Vitamin D supplementation to prevent acute respiratory tract infections: Systematic review and meta-analysis of individual participant data. BMJ, 356, i6583. https://doi.org/10.1136/bmj.i6583
• Tripkovic, L., Lambert, H., Hart, K., Smith, C. P., Bucca, G., Penson, S., Chope, G., Hyppönen, E., Berry, J., Vieth, R., & Lanham-New, S. (2012). Comparison of vitamin D2 and vitamin D3 supplementation in raising serum 25-hydroxyvitamin D status: A systematic review and meta-analysis. American Journal of Clinical Nutrition, 95(6), 1357–1364. https://doi.org/10.3945/ajcn.111.031070
• Wortsman, J., Matsuoka, L. Y., Chen, T. C., Lu, Z., & Holick, M. F. (2000). Decreased bioavailability of vitamin D in obesity. American Journal of Clinical Nutrition, 72(3), 690–693. https://doi.org/10.1093/ajcn/72.3.690
• Yao, P., Bennett, D., Mafham, M., Lin, X., Chen, Z., Armitage, J., & Clarke, R. (2022). Vitamin D and calcium for the prevention of fracture: A systematic review and meta-analysis. JAMA Network Open, 2(12), e1917789. https://doi.org/10.1001/jamanetworkopen.2019.17789